The objective of the ERA-Net Industrial Biotechnology (ERA-IB2) is to contribute to a European Knowledge Based Bio-Economy in the field by reducing fragmentation and promote the exchange of knowledge across borders.
There has been great interest for the 4th ERA-IB2 call (ERA-IB 4th joint call for proposals: Industrial biotechnology for Europe: an integrated approach) from Danish scientists. In the pre-proposal phase 18 pre-proposals with Danish participation were received. At total number of 45 pre-proposals were received with a total requested budget of 56.2 million euros.
For the final round 8 full-proposal applications with Danish participation were received. The amount applied by Danish researchers were 3.3 million euros. DSF has allocated 1 million euros to the call.
Nine projects, of which 3 were with Danish participation, will get funded. You can read more about the three projects with Danish participation below.
Titel: Designer Yeast Strain Library Optimized for Metabolic Engineering Applications (DeYeastLibrary)
Project coordinator: Dr. Kiran Raosaheb Patil, European Molecular Biology Laboratory
Danish partner: Professor Jochen Förster, Technical University of Denmark
Total budget: 1.545.248 euro - hereof 1.272.742 euro in funding
Funding to Danish Scientists: 259.538 euro
Period: 2014-2016
Partners: European Molecular Biology Laboratory, Germany, University of Minho, Portugal, SilicoLife, Portugal, Johann Wolfgang Goethe-Universitat, Germany, Technical University of Denmark, Denmark.
Titel: Integrated Process and Cell Refactoring Systems for Enhanced Industrial Biotechnology (IPCRES)
Project coordinator: Dr. Darren Nesbeth, University College London
Danish partner: Lektor Mhairi Workman, Technical University of Denmark
Total budget: 2.153.090 euro - heraf 1.860.765 euro i funding
Funding to Danish Scientists: 494.538 euro
Period: 2014-2017
Partners: University College London, UK, Jacobs University Bremen, Germany, SilicoLife, Portugal, Technical University of Denmark, Denmark, Autonomous University of Barcelona, Spain, Bio-Prodict, Austria, Ingenza, UK, University of Strathclyde, UK.
Titel: Recovery of high value Proteins from Serum by innovative direct Capture techniques (ProSeCa)
Project coordinator: Professor Matthias Franzreb, Karlsruhe Institute of Technology
Danish partner: Lektor Timothy John Hobley, Technical University of Denmark
Samlet budget: 2.393.209 euro - heraf 1.830.835 euro i funding
Funding to Danish Scientists: 407.422 euro
Period: 2014-2017
Partners: Karlsruhe Institute of Technology, Germany, University of Birmingham, UK, Technical University of Copenhagen, Denmark, fzmb GmbH, Germany, SENOVA Gesellschaft für Biowissenschaft und Technik mbH, Germany.
Read summary of the three projects with Danish participation.
DeYeastLibrary
Professor Jochen Förster from the Novo Nordisk Center for Biosustainability, Technocal university of Denmark, is partner in the €1,5 mio. “DeYeastLibrary” consortium.
Development of optimized cell factories for the production of novel compounds is a time-consuming process and represents a significant cost/time burden. DeYeastLibrary project will help overcoming this hurdle by using cutting-edge computational and experimental tools. The project will exploit the biochemical design principles of nature and will accelerate the development of yeast-based bioprocesses.
IPCRES
Associate Professor Mhairi Workman from Department of Systems Biology, Technical University of Denmark, is partner in the €2,2 mio. “IPCRES” consortium.
The project aims is to convert low-value glycerol, a by-product of biodiesel production, to chiral amino alcohol (CAA) and 1,2-propanediol (PDO). CAA is an intermediate in the manufacturing of some medicines, while PDO is used for the de-icing of aircrafts. The project aims to produce bacterial and yeast strains that can convert glycerol into CAA and PDO.
ProSeCa
Associate Professor Timothy John Hobley from National Food Institute, Technical University of Denmark, is partner in the €2,4 mio. “ProSeCa” consortium.
The project aims to extract biopharmaceuticals from natural sources which often employs overly complicated antiquated procedures. The downstream processing of serum is a case in point; it comprises large numbers of steps of low purification power and consequently delivers poor overall product yields. In ProSeCa focus will be on production of protein based veterinary medicines from horse sera using a fully automated magnetic separator.